We reviewed the options for the manufacture and use of DNA microarrays in the original Chipping Forecast 1 in 1999. Since then, the number of companies that produce microarrays equipment and reagents ...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
StockStory.org on MSN
Life sciences tools & services stocks Q1 results: Benchmarking 10x Genomics (NASDAQ:TXG)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Announcing a new article publication in BIO Integration. The authors of this article developed CellDeathAnalysis (v0.4.0), an ...
AI has been used to develop a universal vaccine that could protect against multiple coronaviruses. The successful Phase 1 ...
Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...
Today, the R Street Institute released a new policy study, “Post-Quantum Cryptography Migration in the United States: ...
Artificial intelligence cloud operator CoreWeave Inc. today launched ARIA, an AI research agent built into the Weights & ...
DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading DNA diagnostics companies' market shares, challenges, DNA diagnostics market ...
The GeneTitan® family of instruments and proven GeneChip® Array Plates from Thermo Fisher Scientific are the first to provide a hands-free, automated solution for monitoring gene expression and genome ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results